CTOR

Citius Oncology
CTOR

16 hedge funds and large institutions have $17M invested in Citius Oncology in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

10.35% more ownership

Funds ownership: 0.32% → 10.66% (+10%)

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.6M
2
+$366K
3
+$258K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$223K
5
Renaissance Technologies
Renaissance Technologies
New York
+$113K

Top Sellers

1
-$465K
2
-$31.3K
3
-$16.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$15.6M
Vanguard Group
2
Vanguard Group
Pennsylvania
$366K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$339K
XT
4
XTX Topco
Cayman Islands
$258K
Renaissance Technologies
5
Renaissance Technologies
New York
$113K
State Street
6
State Street
Massachusetts
$87.1K
IA
7
IFP Advisors
Florida
$67.4K
Northern Trust
8
Northern Trust
Illinois
$44.2K
Citadel Advisors
9
Citadel Advisors
Florida
$35.9K
Osaic Holdings
10
Osaic Holdings
Arizona
$25.2K
TRCT
11
Tower Research Capital (TRC)
New York
$24K
AWA
12
Arkadios Wealth Advisors
Georgia
$23.7K
Bank of America
13
Bank of America
North Carolina
$536
UBS Group
14
UBS Group
Switzerland
$112
Morgan Stanley
15
Morgan Stanley
New York
$10
FFA
16
Farther Finance Advisors
California
$6
Jane Street
17
Jane Street
New York
–